Metastatic Squamous Cell Carcinoma of the Lung: ASCO Tumor Boards

This course is available as part of the 2016 ASCO Tumor Boards bundle.

This is a case-based activity that includes discussion of a 63 year old woman with a history of hypertension who presents to her primary care physician with a two-month history of shortness of breath on moderate exertion and a dry cough. The patient is a current one pack per day cigarette smoker for the past 32 years. A chest x-ray and CT scan of the chest and upper abdomen show a 4.2 cm right lower lobe central lung mass, subcarinal lymphadenopathy, and several liver lesions concerning for metastases. A CT-guided biopsy of the liver lesion is performed, showing squamous cell carcinoma.

At the end of the course, you should be able to:

  • Describe the role of first-line systemic therapy for patients with metastatic lung squamous cell carcinomas.
  • Recognize options for the treatment of relapsed/refractory squamous cell carcinoma of the lung.
  • Analyze the role of novel approaches including immunotherapy and targeted therapies in lung squamous cell carcinoma.

This activity was made available on February 17, 2016 and will be reviewed on an annual basis to determine continued availability. A maximum of 1 AMA PRA Category 1 Credit(2)™ credit is available for this module.

Please Note: All new content produced in 2016 as part of the Tumor Board series is available for purchase in the ASCO University bookstore. Please click on the green “Purchase” button to the left in order to add this product to your account.

IMPORTANT NOTE: This course expires on February 17, 2019. Participants must complete all necessary course components by this date.